Détail - canceropole-wordpress

[Postoperative complications and long-term outcomes of transplantation with expended criteria donors transplants].

Fellmann M, Balssa L, Clément E, Frey P, Frontczak A, Bernardini S, Chabannes É, Guichard G, Bittard H, Kleinclauss F

Prog. Urol.. 2020 Aug 16;:

Molecular and nanoscale evaluation of N-cadherin expression in invasive bladder cancer cells under control conditions or GW501516 exposure.

Elie-Caille C, Lascombe I, Péchery A, Bittard H, Fauconnet S

Mol. Cell. Biochem.. 2020 Jun 9;:

Effects of Obesity on Postoperative Complications and Graft Survival After Kidney Transplantation.

Fellmann M, Balssa L, Clément E, Frey P, Frontczak A, Bernardini S, Chabannes É, Guichard G, Bittard H, Kleinclauss F

Transplant. Proc.. 2020 Jun 1;:

Evaluation and comparison of scoring systems for predicting stone-free status after flexible ureteroscopy for renal and ureteral stones.

Richard F, Marguin J, Frontczak A, Barkatz J, Balssa L, Bernardini S, Chabannes E, Guichard G, Bittard H, Kleinclauss F

PLoS ONE. 2020 ;15(8):e0237068

[Concordances and predictors of biopsies in renal tumors].

Richard V, Detrée P, Frontczak A, Balssa L, Bernardini S, Chabannes E, Guichard G, David A, Manzoni P, Bittard H, Kleinclauss F

Prog. Urol.. 2019 Oct 16;:

Down-regulation of A-FABP predicts non-muscle invasive bladder cancer progression: investigation with a long term clinical follow-up.

Mathis C, Lascombe I, Monnien F, Bittard H, Kleinclauss F, Bedgedjian I, Fauconnet S, Valmary-Degano S

BMC Cancer. 2018 Dec 10;18(1):1239

Cell death and restoration of TRAIL-sensitivity by ciglitazone in resistant cervical cancer cells.

Plissonnier ML, Fauconnet S, Bittard H, Mougin C, Rommelaere J, Lascombe I

Oncotarget. 2017 Dec 8;8(64):107744-107762

Cross-cultural adaptation and validation of the French version of the Expanded Prostate cancer Index Composite questionnaire for health-related quality of life in prostate cancer patients.

Anota A, Mariet AS, Maingon P, Joly F, Bosset JF, Guizard AV, Bittard H, Velten M, Mercier M

Health Qual Life Outcomes. 2016 Dec;14(1):168

Apoptotic effect of the selective PPARβ/δ agonist GW501516 in invasive bladder cancer cells.

Péchery A, Fauconnet S, Bittard H, Lascombe I

Tumour Biol.. 2016 Nov;37(11):14789-14802

Flexible Ureterorenoscopy for Renal and Proximal Ureteral Stone in Patients with Previous Ureteral Stenting: Impact on Stone-Free Rate and Morbidity.

Dessyn JF, Balssa L, Chabannes E, Jacquemet B, Bernardini S, Bittard H, Guichard G, Kleinclauss F

J. Endourol.. 2016 Oct;30(10):1084-1088

[Flexible ureterorenoscopy vs percutaneous nephrolithotomy for renal stone management: Retrospective study].

Palmero X, Balssa L, Bernardini S, Chabannes E, Guichard G, Bittard H, Kleinclauss F

Prog. Urol.. 2016 Sep;26(9):500-6

[Impact of obesity on pathologic outcomes and biochemical reccurence after radical prostatectomy].

Balssa L, Pastori J, Lillaz J, Panouilleres M, Guichard G, Bernardini S, Chabannes E, Bittard H, Thiery-Vuillemin A, Kleinclauss F

Prog Urol. 2015 Apr 16. pii: S1166-7087(15)00101-3

Comparison of the efficacy and morbidity of flexible ureterorenoscopy for lower pole stones compared with other renal locations.

Jacquemet B, Martin L, Pastori J, Bailly V, Guichard G, Bernardini S, Chabannes E, Bittard H, Kleinclauss F

J. Endourol.. 2014 Oct;28(10):1183-7

[Flexible ureterorenoscopy in obese patients: results from a large monocenter cohort].

Laclergerie F, Jacquemet B, Guichard G, Bernardini S, Chabannes E, Martin L, Pastori J, Bailly V, Bittard H, Kleinclauss F

Prog Urol. 2014 Sep;24(10):634-9

[Meteo-U-rology: climate impact on urological emergencies].

Bailly V, Le Ray I, Bardonnaud N, Pillot P, Martin L, Pastori J, Balssa L, Guichard G, Bittard H, Kleinclauss F

Prog Urol. 2014 Jul;24(9):535-9

[Existence of pattern 5 on radical prostatectomy: poor prognostic factor associated with a lower biochemical recurrence-free survival].

Pastori J, Balssa L, Lillaz J, Guichard G, Chabannes E, Bernardini S, Bittard H, Thiery-Vuillemin A, Kleinclauss F

Prog Urol. 2014 Jun;24(7):433-40

The PPARbeta agonist L-165041 promotes VEGF mRNA stabilization in HPV18-harboring HeLa cells through a receptor-independent mechanism.

Roche E, Lascombe I, Bittard H, Mougin C, Fauconnet S

Cell Signal. 2014 Feb;26(2):433-43

[Evaluation of the activity of a urological emergency unit in university hospital].

Martin L, Pillot P, Bardonnaud N, Lillaz J, Chabannes E, Bernardini S, Guichard G, Bittard H, Kleinclauss F

Prog Urol. 2014 Jan;24(1):62-6

Outcomes of renal transplantation in obese recipients.

Bardonnaud N, Pillot P, Lillaz J, Delorme G, Chabannes E, Bernardini S, Guichard G, Bittard H, Kleinclauss F

Transplant Proc. 2012 Nov;44(9):2787-91

Risk factors for surgical complications after renal transplantation and impact on patient and graft survival.

Pillot P, Bardonnaud N, Lillaz J, Delorme G, Chabannes E, Bernardini S, Guichard G, Bittard H, Kleinclauss F

Transplant Proc. 2012 Nov;44(9):2803-8

[Accuracy of prostate biopsies to evaluate tumor location in prostate cancer].

Lillaz J, Delorme G, Guichard G, Bernardini S, Chabannes E, Bittard H, Kleinclauss F

Prog Urol. 2012 Jun;22(7):408-14

[Muscularis mucosae invasion: prognostic factor for intravesical BCG immunotherapy failure for T1 bladder carcinoma].

Nguyen-Huu Y, Delorme G, Lillaz J, Bedgedjian I, Le Ray-Ferrieres I, Chabannes E, Bernardini S, Guichard G, Bittard H, Kleinclauss F

Prog Urol. 2012 May;22(5):284-90

Ureterorenoscopy with holmium-yttrium-aluminum-garnet fragmentation is a safe and efficient technique for stone treatment in patients with a body mass index superior to 30 kg/m2.

Delorme G, Huu YN, Lillaz J, Bernardini S, Chabannes E, Guichard G, Bittard H, Kleinclauss F

J. Endourol.. 2012 Mar;26(3):239-43

[Urinary complications of one-stitch ureteroneocystostomy in renal transplantation].

Bardonnaud N, Pillot P, Guichard G, Lillaz J, Delorme G, Nguyen-Huu Y, Chabannes E, Bernardini S, Bittard H, Kleinclauss F

Prog Urol. 2012 Jan;22(1):22-9

[Immunosuppression in kidney transplantation].

Balssa L, Bittard H, Kleinclauss F,

Prog. Urol.. 2011 Apr;21(4):250-3

The antidiabetic drug ciglitazone induces high grade bladder cancer cells apoptosis through the up-regulation of TRAIL.

Plissonnier ML, Fauconnet S, Bittard H, Lascombe I

PLoS One. 2011;6(12):e28354

Wegener's granulomatosis: a rare cause of hydronephrosis.

Lillaz J, Bernardini S, Algros MP, Bittard H, Kleinclauss F

Case Report Med. 2011;2011:814794

Insights on distinct pathways of thiazolidinediones (PPARgamma ligand)-promoted apoptosis in TRAIL-sensitive or -resistant malignant urothelial cells.

Plissonnier ML, Fauconnet S, Bittard H, Lascombe I

Int J Cancer. 2010 Oct 15;127(8):1769-84.

Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.

Wallerand H, Cai Y, Wainberg ZA, Garraway I, Lascombe I, Nicolle G, Thiery JP, Bittard H, Radvanyi F, Reiter RR

Urol Oncol. 2010 Mar-Apr;28(2):180-8

Expression analysis of VEGF-A and VEGF-B: Relationship with clinicopathological parameters in bladder cancer

Fauconnet S, Bernardini S, Lascombe I, Boiteux G, Clairotte A, Monnien F, Chabannes E, Bittard H

Oncol Rep. 2009 Jun;21(6):1495-504.

The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking status.

Fondrevelle ME, Kantelip B, Reiter RE, Chopin DK, Thiery JP, Monnien F, Bittard H, Wallerand H

Urol Oncol. 2009 May-Jun;27(3):268-76

A-FABP, a candidate progression marker of human transitional cell carcinoma of the bladder, is differentially regulated by PPAR in urothelial cancer cells.

Boiteux G, Lascombe I, Roche E, Plissonnier ML, Clairotte A, Bittard H, Fauconnet S

Int J Cancer. 2009 Apr 15;124(8):1820-8.

Hospital costs of renal transplant management.

Chaumard N, Fagnoni P, Nerich V, Limat S, Dussaucy A, Chalopin JM, Bittard H, Woronoff-Lemsi MC

Transplant Proc. 2008 Dec;40(10):3440-4.

Accuracy of ultrasonography in diagnosis of testicular rupture after blunt scrotal trauma.

Guichard G, El Ammari J, Del Coro C, Cellarier D, Loock PY, Chabannes E, Bernardini S, Bittard H, Kleinclauss F

Urology. 2008 Jan;71(1):52-6.

Lymphocyte subsets in renal transplant recipients with de novo genitourinary malignancies.

Guichard G, Rebibou JM, Ducloux D, Simula-Faivre D, Tiberghien P, Chalopin JM, Bittard H, Saas P, Kleinclauss F

Urol Int. 2008;80(3):257-63

[Management of renal colic in pregnant women, based on a series of 48 cases]

Guichard G, Fromajoux C, Cellarier D, Loock PY, Chabannes E, Bernardini S, Maillet R, Bittard H, Kleinclauss F

Prog Urol. 2008 Jan;18(1):29-34

[Vascular prostheses and renal transplantation].

Cellarier D, Guichard G, Loock PY, Bernardini S, Chabannes E, Bittard H, Kleinclauss F

Prog Urol. 2006 Nov;16(5):554-8.

[Conservative management of Corynebacterium urealyticum encrusted cystitis].

Khallouk A, Wallerand H, Kleinclauss F, Bittard H, Bernardini S

Prog Urol. 2006 Sep;16(4):496-8.

[Atypical cysts and risk of renal cancer: value and danger of the Bosniak classification].

Loock PY, Debiere F, Wallerand H, Bittard H, Kleinclauss F

Prog Urol. 2006 Jun;16(3):292-6.

[Simultaneous embolization of a large arteriovenous fistula and a renal pseudoaneurysm].

Khallouk A, El-Ammari JE, Wallerand H, Kleinclauss F, Bittard H, Bernardini S

Prog Urol. 2006 Jun;16(3):373-5.

Priapism related to an antiphospholipid syndrome in a patient with systemic lupus erythematosus.

Gil H, Magy N, Kleinclauss F, Meaux-Ruault N, Bittard H, Dupond JL

Clin Exp Rheumatol. 2006 Mar-Apr;24(2):217.

[Urologic cancer in patients with kidney transplantation].

Guichard G, Wallerand H, Bittard H, Chalopin JM, Kleinclauss F

Prog Urol. 2006 Feb;16(1 Suppl):16-8.

Expression of E-cadherin and alpha-, beta-, gamma-catenins in patients with bladder cancer: identification of gamma-catenin as a new prognostic marker of neoplastic progression in T1 superficial urothelial tumors.

Clairotte A, Lascombe I, Fauconnet S, Mauny F, Felix S, Algros MP, Bittard H, Kantelip B

Am J Clin Pathol. 2006 Jan;125(1):119-26.

Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion.

Kleinclauss F, Perruche S, Masson E, de Carvalho Bittencourt M, Biichle S, Remy-Martin JP, Ferrand C, Martin M, Bittard H, Chalopin JM, Seilles E, Tiberghien P, Saas P

Cell Death Differ. 2006 Jan;13(1):41-52.

[Bladder leiomyoma treated by transurethral endoscopic resection].

Khallouk A, Wallerand H, Kleinclauss F, Debiere F, Bittard H, Bernardini S

Prog Urol. 2005 Dec;15(6):1135-7.

[Prospective study of the results at 2 years of one or two cycles of BCG endovesical instillations in the urothelial tumors of the bladder pT1 G3 after completed transurethral resection].

Rischmann P, Game X, Mazerolles C, Bittard H, Bouchot O, Descottes JL, Chopin D

Prog Urol. 2005 Dec;15(6 Suppl 1):1266-70.

Sensitive allele-specific PCR assay able to detect FGFR3 mutations in tumors and urine from patients with urothelial cell carcinoma of the bladder.

Bakkar AA, Quach V, Le Borgne A, Toublanc M, Henin D, Wallerand H, Radvanyi F, Bittard H, Ravery V, Gibod LB, de Medina SG, Chopin DK, Grandchamp B

Clin Chem. 2005 Aug;51(8):1555-7.

[Erectile dysfunction in renal failure patients and renal transplant recipients].

Kleinclauss F, Kleinclauss C, Bittard H

Prog Urol. 2005 Jun;15(3):447-55; discussion 455-6.

[Priapism and activated protein C resistance].

Guichard G, Henry PC, Bittard H, Kleinclauss F

Prog Urol. 2005 Apr;15(2):337-8; discussion 338.

Angiogenesis and bladder cancer: role of vascular endothelial growth factor.

LASCOMBE I, FAUCONNET S, CHABANNES E, BITTARD H

In : Progress in Bladder Cancer Research. Pp. 19-65, vol 6, 2005.

Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens.

Wallerand H, Bakkar AA, de Medina SG, Pairon JC, Yang YC, Vordos D, Bittard H, Fauconnet S, Kouyoumdjian JC, Jaurand MC, Zhang ZF, Radvanyi F, Thiery JP, Chopin DK

Carcinogenesis. 2005 Jan;26(1):177-84